Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 27.07.2021 at 12:00 PM CEST
Settings

Settings

Goto Application

1. CU23582 - PÉPTIDOS CON CAPACIDAD ANTI-TUMORAL E INMUNOMODULADORA

CU23582PÉPTIDOS CON CAPACIDAD ANTI-TUMORAL E INMUNOMODULADORA
Appl.Date 24.02.2006
Appl.No 20060047 Applicant CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA Pub.Kind A1
Inclusion Criteria IC5
Sole priority inside the family.
Pub.Date 30.10.2010
AR059608PEPTIDOS CON CAPACIDAD ANTI - TUMORAL E INMUNOMODULADORA
Appl.Date 22.02.2007
Appl.No P070100749 Applicant CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA Pub.Kind A1 Pub.Lang es
Inclusion Criteria IC6
Connected by priority field.
Pub.Date 16.04.2008
EP1992638IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES
Appl.Date 23.02.2007
Appl.No 07711100 Applicant CT INGENIERIA GENETICA BIOTECH Pub.Kind A1,B1 Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 19.11.2008
BRPI0708148PEPTÍDEOS COM CAPACIDADE ANTITUMORAL E IMUNOMODULADORA PROVENIENTES DA REGIÃO 32-51 DA PROTEÍNA LALF, COMPOSTOS QUÍMICOS MIMÉTICOS AOS PEPTÍDEOS, COMPOSIÇÃO FARMACÊUTICA E USO DOS PEPTÍDEOS E COMPOSTOS QUÍMICOS
Appl.Date 23.02.2007
Appl.No PI0708148 Applicant CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA Pub.Kind A2,B1 Pub.Lang pt
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 04.04.2011
ES2358845PEPTIDOS INMUNOMODULARES Y ANTITUMORALES.
Appl.Date 23.02.2007
Appl.No 07711100 Applicant CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA Pub.Kind T3 Pub.Lang es
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 16.05.2011
US20090221508Immunomodulatory and anti-tumour peptides
Appl.Date 23.02.2007
Appl.No 12278990 Applicant Centro de Ingenieria Genetica y Biotecnologia Pub.Kind A1,B2 Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 03.09.2009
RU0002430109IMMUNOMODULATORY AND ANTINEOPLASTIC PEPTIDES
Appl.Date 23.02.2007
Appl.No 2008137968/04 Pub.Kind C2
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 27.09.2011
CN101426813 Immunomodulatory and anti-tumour peptides
Appl.Date 23.02.2007
Appl.No 200780013884.2 Applicant Ct Ingenieria Genetica Biotech Pub.Kind A,B Pub.Lang zh
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 06.05.2009
AU2007218671Immunomodulatory and anti-tumour peptides
Appl.Date 23.02.2007
Appl.No 2007218671 Applicant Centro de Ingenieria Genetica Y Biotecnologia Pub.Kind B2
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 18.09.2008
JP2009527510免疫調節及び抗腫瘍ペプチド
Appl.Date 23.02.2007
Appl.No 2008555601 Applicant セントロ デ インジエニエリア ジエネテイカ イ バイオテクノロジア Pub.Kind A,A5,B2 Pub.Lang ja
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 30.07.2009
WO/2007/095867IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES
Appl.Date 23.02.2007
Appl.No PCT/CU2007/000006 Applicant ACEVEDO CASTRO, Boris, Ernesto Pub.Kind A Pub.Lang es
Inclusion Criteria IC1
PCT application from which the family originated.
Pub.Date 30.08.2007
CA2638828IMMUNOMODULATORY AND ANTI-TUMOR PEPTIDES DERIVED FROM LALF
Appl.Date 11.08.2008
Appl.No 2638828 Applicant CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA Pub.Kind A1,C Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 30.08.2007
ZA2008/07034IMMUNOMODULATORY AND ANTI-TUMOR PEPTIDES
Appl.Date 14.08.2008
Appl.No 2008/07034 Applicant CENTRO DE INGENIERIA GENETICA Y BIOTECHNOLOGIA Pub.Kind B Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 24.06.2009
IN1788/MUMNP/2008IMMUNOMODULATERY AND ANTI-TUMOR PEPTIDES
Appl.Date 20.08.2008
Appl.No 1788/MUMNP/2008 Applicant CENTRO DE INGENIERÍA GENÉTICA BIOTECNOLOGÍA Pub.Kind A,B Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 03.10.2008
MXMX/a/2008/010893IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES
Appl.Date 22.08.2008
Appl.No MX/a/2008/010893 Applicant CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA.* Pub.Kind A Pub.Lang es
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 31.10.2008
KR1020080106446IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES
Appl.Date 23.09.2008
Appl.No 1020087023166 Applicant CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA Pub.Kind A,B1
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 05.12.2008